全文获取类型
收费全文 | 2715篇 |
免费 | 182篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 76篇 |
妇产科学 | 33篇 |
基础医学 | 321篇 |
口腔科学 | 60篇 |
临床医学 | 186篇 |
内科学 | 775篇 |
皮肤病学 | 30篇 |
神经病学 | 204篇 |
特种医学 | 136篇 |
外科学 | 500篇 |
综合类 | 10篇 |
预防医学 | 62篇 |
眼科学 | 66篇 |
药学 | 128篇 |
中国医学 | 6篇 |
肿瘤学 | 319篇 |
出版年
2024年 | 7篇 |
2023年 | 41篇 |
2022年 | 69篇 |
2021年 | 131篇 |
2020年 | 67篇 |
2019年 | 82篇 |
2018年 | 85篇 |
2017年 | 80篇 |
2016年 | 76篇 |
2015年 | 102篇 |
2014年 | 91篇 |
2013年 | 115篇 |
2012年 | 198篇 |
2011年 | 170篇 |
2010年 | 97篇 |
2009年 | 88篇 |
2008年 | 139篇 |
2007年 | 154篇 |
2006年 | 124篇 |
2005年 | 127篇 |
2004年 | 112篇 |
2003年 | 91篇 |
2002年 | 99篇 |
2001年 | 46篇 |
2000年 | 46篇 |
1999年 | 47篇 |
1998年 | 41篇 |
1997年 | 27篇 |
1996年 | 36篇 |
1995年 | 23篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 31篇 |
1991年 | 32篇 |
1990年 | 19篇 |
1989年 | 21篇 |
1988年 | 15篇 |
1987年 | 14篇 |
1986年 | 19篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 12篇 |
1975年 | 7篇 |
1972年 | 7篇 |
1969年 | 6篇 |
1967年 | 7篇 |
排序方式: 共有2941条查询结果,搜索用时 15 毫秒
61.
Shirahama Shintaro Kaburaki Toshikatsu Takada Sachiko Nakahara Hisae Tanaka Rie Komae Keiko Fujino Yujiro Kawashima Hidetoshi Aihara Makoto 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(3):639-645
Graefe's Archive for Clinical and Experimental Ophthalmology - To clarify the prevalence of secondary glaucoma (SG) and its speed of progression in patients with herpes simplex virus... 相似文献
62.
63.
64.
Michio Kuwahara Syoko Hasumi Shintaro Mandai Tomomi Tanaka Satomi Shikuma Wataru Akita Yoshihiro Mori Sei Sasaki 《Clinical and experimental nephrology》2014,18(5):755-762
Background
Erythropoiesis-stimulating agents (ESAs) are standard therapy for chronic kidney disease (CKD) patients with renal anemia. However, few studies have compared the effects of different ESAs on anemia in identical pre-dialysis CKD patients.Methods
Seventy-nine patients who switched from epoetin beta to darbepoetin alfa (Group 1), and 82 patients who switched from darbepoetin alfa to epoetin beta pegol (Group 2) were enrolled in this study. Clinical and laboratory parameters were assessed for 6 months before and after switching ESAs. The prevalence of adverse events, the dose conversion ratio of ESAs, and the frequency of ESA administration were also analyzed.Results
Analysis of variance showed that switching ESAs did not significantly change hemoglobin levels for the study duration in both groups (mean hemoglobin 10.3–10.5 g/dL in Group 1 and 10.4–10.7 g/dL in Group 2). Estimated glomerular filtration rate, blood pressure, transferrin saturation, ferritin, and albumin remained constant in both groups. The prevalence of adverse effects was quite low (0–3.8 %) during both 6-month study periods. The mean dose conversion ratio for epoetin beta:darbepoetin alfa was 163.7 units:1 μg and for darbepoetin alfa:epoetin beta pegol was 1.08 μg:1 μg. The intervals of ESA administration significantly differed (epoetin beta pegol > darbepoetin alfa > epoetin beta).Conclusions
Epoetin beta, darbepoetin alfa, and epoetin beta pegol are effective and well-tolerated agents for managing anemia in Japanese pre-dialysis CKD patients. The intervals of ESA administration to maintain a patient’s target hemoglobin were longer in the order of epoetin beta pegol > darbepoetin alfa > epoetin beta. 相似文献65.
Kawami Noriyuki Hoshino Shintaro Hoshikawa Yoshimasa Tanabe Tomohide Koeda Mai Momma Eri Takenouchi Nana Hanada Yuriko Kaise Mitsuru Iwakiri Katsuhiko 《Esophagus》2022,19(2):367-373
Esophagus - This study investigated potential determinants of reflux perception in patients with non-erosive reflux disease (NERD) who had reflux-related symptoms on potassium-competitive acid... 相似文献
66.
Koeda Mai Tanabe Tomohide Kitasako Yuichi Momma Eri Hoshikawa Yoshimasa Hoshino Shintaro Kawami Noriyuki Kaise Mitsuru Iwakiri Katsuhiko 《Esophagus》2021,18(4):900-907
Esophagus - There is no consensus on the relationship between saliva secretion and non-erosive reflux disease (NERD). In this study, saliva secretion and salivary epidermal growth factor (EGF) in... 相似文献
67.
Tanabe Tomohide Koeda Mai Kitasako Yuichi Momma Eri Hoshikawa Yoshimasa Hoshino Shintaro Kawami Noriyuki Kaise Mitsuru Iwakiri Katsuhiko 《Esophagus》2021,18(3):676-683
Esophagus - Salivary secretion in patients with proton-pump inhibitor (PPI)-resistant severe reflux esophagitis has not been examined. In this study, saliva secretion and salivary epidermal growth... 相似文献
68.
Takashi Ueyama Fuminobu Ishikura Akiko Matsuda Toshihiko Asanuma Kazuki Ueda Masao Ichinose Ken Kasamatsu Takuzo Hano Takashi Akasaka Yoshihiro Tsuruo Keiko Morimoto Shintaro Beppu 《Circulation journal》2007,71(4):565-573
BACKGROUND: Takotsubo cardiomyopathy is triggered by emotional or physical stress especially in post-menopausal women. A reduction in estrogen levels following menopause might underlie the high incidence of takotsubo cardiomyopathy. METHODS AND RESULTS: The left ventricular contraction between ovariectomized rats (OVX) and OVX with estrogen supplementation (OVX + E) while subjected to immobilization stress (IMO) was compared. The IMO in combination with general anesthesia impaired the left ventricular contraction in both OVX and OVX + E. Estrogen supplementation tended to improve the IMO-induced cardiac dysfunction and significantly attenuated the increase of blood pressure and heart rate. To understand the protective mechanism of estrogen, the expression of c-fos mRNA, a marker of cellular activation was compared. The mRNA expression of cardioprotective substances in the heart was also investigated. In the OVX + E, the levels of c-fos mRNA were significantly decreased in the paraventricular hypothalamic nucleus, adrenal gland and left ventricle, suggesting that an increase of estrogen attenuates the emotional stress-induced hypothalamo-sympatho-adrenal outflow from the central nervous system to the target organs. An expression of heat shock protein 70 and atrial natriuretic peptide was significantly augmented in the OVX + E. CONCLUSIONS: These data suggest that estrogen supplementation partially prevents emotional stress-induced cardiovascular responses both by indirect action on the nervous system and by direct action on the heart. 相似文献
69.
Shintaro Sueyoshi Hirohito Umeno Takashi Kurita Mioko Fukahori Shun-ichi Chitose 《Auris, nasus, larynx》2021,48(5):949-955
ObjectiveFibrotic changes in the vocal fold mucosa have been observed in patients with vocal fold scarring, aged vocal fold, and sulcus vocalis, which often lead to severe voice disorders. Previous research suggests that the basic fibroblast growth factor (b FGF) improves variations in vocal fold properties [1,2]. Although clinical studies on b FGF treatments have been conducted [3,4,5], these studies only demonstrated the efficacy of this drug over a short period. The present study is the first to investigate the long-term efficacy of b FGF treatment.Methodsb FGF injections were performed in six patients from January of 2016 to December of 2017 at our institution. Patient follow-up continued for at least two years after the last injection. Three patients had vocal fold scarring, two had aged vocal fold atrophy, and one patient had sulcus vocalis. Each vocal fold was injected with 10 µg of b FGF four times. Voice and stroboscopic examinations were performed after surgery (at one month, three months, six months, one year, two years). Fundamental frequency, maximum phonation time (MPT), mean flow rate (MFR), amplitude perturbation quotient (APQ), pitch perturbation quotient (PPQ), and noise-to-harmonic ratio (NHR), and voice handicap index-10 (VHI-10) were examined and compared statistically between the pretreatment time and at each posttreatment time point.ResultsThe speaking F0 had an obvious decreasing tendency, with significant differences suggesting the increase in volume in the vocal folds. Aerodynamic parameters also showed small improvements. The most remarkable improvement was observed in the acoustic parameters, indicating that the treatment could improve the vocal fold to make vibrations symmetrically and regularly for a long period. Achievement of symmetry and regularity on vocal fold vibrations suggested the property changes had happened in the vocal folds. Consequently, the score of VHI-10 had improved, indicating high patient satisfaction with this treatment.Conclusionb FGF injections could be a reliable treatment option for diseases that deteriorate the property of vocal fold. 相似文献
70.
Shun-ichi Chitose Masahiro Haraguchi Shuji Nagata Reiji Katayama Kiminori Sato Mioko Fukahori Shintaro Sueyoshi Takashi Kurita Toshi Abe Tadashi Nakashima 《Dysphagia》2014,29(3):387-395
The purpose of this study was to analyze passive motion of the para- and retropharyngeal space (PRS) during swallowing using dynamic magnetic resonance imaging (MRI). We conducted a preliminary study involving 30 healthy volunteers who underwent dynamic MRI. Consecutive MRI axial images were obtained by examining the plane parallel to the hard palate at the level of the anterior inferior corner of C2. Anterior displacement of the posterior pharyngeal wall (PPW) was measured as a motion index of pharyngeal contraction. The displacement and internal angle of the bilateral external and internal carotid arteries (ECA and ICA) and the bilateral centroids of the PRS area, as well as the increase in PRS area, were calculated at rest and at maximum pharyngeal contraction. In most participants, the bilateral ECA, ICA, and centroids were anterointernally displaced by pharyngeal contraction. The normalized ECA displacement (r = 0.64, r 2 = 0.41), normalized ICA displacement (r = 0.60, r 2 = 0.37), and normalized centroid displacement (r = 0.43, r 2 = 0.19) were more than moderately positively correlated with the normalized PPW displacement. The normalized PRS area increase (r = 0.35, r 2 = 0.12) was weakly positively correlated with the normalized PPW displacement. These results revealed that PRS area increased as the ECA and ICA were drawn anterointernally via its passive motion by pharyngeal contraction. 相似文献